UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000022474
Receipt No. R000024508
Official scientific title of the study Study of the intervention method of rehabilitation of patients who have repeated chemotherapy with blood cancer
Date of disclosure of the study information 2016/09/01
Last modified on 2016/05/26 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study of the intervention method of rehabilitation of patients who have repeated chemotherapy with blood cancer
Title of the study (Brief title) Study of the intervention method of rehabilitation of patients who have repeated chemotherapy with blood cancer
Region
Japan

Condition
Condition blood cancer
Classification by specialty
Hematology and clinical oncology Nursing
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Intervention method of the rehabilitation to prevemt a physical strength decline to the patient who piled up chemotherapy by blood cancer is considered.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Utilization on a lehabilitation brochure and support according to the state of the patient lead to effective rehabilitation intervention from the hospitalization time as well as the rehabilitation added to treatment coolness.
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Receiving chemotherapy after hospitalization since 2015 to the blood tumor internal medicine of the hospital patients who particpated in any of the intervention of rehabilitation due to physical therapists rehabilitation or ward by rehabilitation brochure gymnastics.
Key exclusion criteria No.
Target sample size 10

Research contact person
Name of lead principal investigator Erika Konishi
Organization Shikoku Cancer Center
Division name Nurs
Address Ehime Matsuyama minamiumemoto 160
TEL 089-999-1111
Email erkonishi@shikoku-cc.go.jp

Public contact
Name of contact person Erika Konishi
Organization Shikoku Cancer Center
Division name Nurs
Address Ehime Matsuyama minamiumemoto 160
TEL 0899991111
Homepage URL
Email erkonishi@shikoku-cc.go.jp

Sponsor
Institute Shikoku Cancer Center
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization No.
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 四国がんセンター(愛媛県)

Other administrative information
Date of disclosure of the study information
2016 Year 09 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 02 Month 26 Day
Anticipated trial start date
2016 Year 02 Month 26 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Words and deeds of the subject to the question of researchers.

Management information
Registered date
2016 Year 05 Month 26 Day
Last modified on
2016 Year 05 Month 26 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024508